CAELUM Co., Ltd. (KOSDAQ:258610)
1,135.00
+47.00 (4.32%)
At close: Aug 18, 2026
CAELUM Revenue
CAELUM had revenue of 26.64B KRW in the quarter ending March 31, 2026, a decrease of -14.64%. This brings the company's revenue in the last twelve months to 77.13B, down -18.58% year-over-year. In the year 2025, CAELUM had annual revenue of 81.70B, down -16.06%.
Revenue (ttm)
77.13B
Revenue Growth
-18.58%
P/S Ratio
0.53
Revenue / Employee
2.03B
Employees
38
Market Cap
41.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.70B | -15.63B | -16.06% |
| Dec 31, 2024 | 97.33B | 12.78B | 15.12% |
| Dec 31, 2023 | 84.55B | 6.70B | 8.61% |
| Dec 31, 2022 | 77.84B | 24.92B | 47.09% |
| Dec 31, 2021 | 52.92B | 41.43B | 360.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CoAsia CM Co.,Ltd | 243.66B |
| Korea Arlico Pharm | 199.14B |
| BORATR CO. | 105.14B |
| Wysiwyg Studios | 94.89B |
| Handok Clean Tech | 72.31B |
| China Crystal New Material Holdings | 58.98B |
| Kolmar BioTech | 40.30B |
| Egis Co.,Ltd | 21.41B |